Study tests gut bacteria to predict response in spine arthritis
Part of Bones, joints & muscles clinical trials.
This study looks at your gut bacteria (from a stool sample) to see whether it can predict how well you will respond to biologic medicines for spondyloarthritis. It may help doctors choose the most effective treatment for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been diagnosed with spondyloarthritis (or axial psoriatic arthritis)
- You have never taken biologic treatment (biotherapy) before
- Your doctor recommends starting anti-TNF or anti–IL-17 treatment
- In the last month, you have not used antibiotics, probiotics, or prebiotics
- You can give written consent and you are covered by the national social security system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stool (poop) samples to see whether gut bacteria patterns can help identify certain inflammatory arthritis conditions in people who have Crohn’s disease or axial spondyloarthritis. It’s mainly about matching stool “biomarkers” to diagnoses, which may help doctors recognize these conditions more accurately in the future.
This study compares the gut microbiome (the bacteria in your intestines) in adults with spondyloarthritis or rheumatoid arthritis versus healthy adults. It aims to better describe differences that may help explain these diseases.
This study looks at whether changes in the gut bacteria (called microbiome dysbiosis) are linked to spondyloarthritis. It compares people with the condition to people without it who are already planning a digestive scope for another reason.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This study looks at how the “gut microbiome” (the helpful bacteria in the intestines) changes in children with juvenile enthesitis-related arthritis. It may help doctors understand how different treatment approaches affect gut bacteria over time.
This study looks at changes in gut bacteria over time in people with systemic sclerosis (a connective tissue disease). It also compares them with healthy adults to understand what gut bacteria patterns may be linked to this condition.
Hear when a new Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.